ENDEAVOR PHARMACEUTICALS has a total of 22 patent applications. Its first patent ever was published in 1994. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, measurement and organic fine chemistry are POP TEST CORTISOL LLC, COSMO SPA and TOKAI PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Mexico | 3 | |
#5 | United States | 3 | |
#6 | Australia | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Steroids |
# | Name | Total Patents |
---|---|---|
#1 | Leonard Thomas W | 14 |
#2 | Whittle Robert R | 10 |
#3 | Sancilio Frederick D | 9 |
#4 | Hill Edward N | 9 |
#5 | Shirazi Dean G | 5 |
#6 | Schlipp Katherin M | 5 |
#7 | Waldon R Forrest | 4 |
#8 | Thomas W Leonard | 2 |
#9 | Caldwell Henry C | 1 |
#10 | Swarbrick James | 1 |
Publication | Filing date | Title |
---|---|---|
WO03057855A2 | Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex | |
WO02092102A2 | Treatment of conditions relating to hormone deficiencies by administration of progestins | |
WO0168669A1 | 6-oxygenated steroidal estrogens with aromatic a and b rings | |
US6660726B2 | Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same | |
US6855703B1 | Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds |